CH BIOTECH SER (08037): Huada Songhe subscribes to DYNAM Japanic Healthcare's shares through convertible loans, holding a maximum of 6.25% stake.

CH BIOTECH SER (08037) announced that the formal agreement regarding the investment was signed on July 11, 2025. The investment will be carried out in the following ways: (1) According to the convertible loan agreement, Huada Songhe will provide a loan of 30 million RMB to Pengbo (Hainan); (2) According to the warrant agreement, DYNAM Japanic Healthcare will grant warrants to Huada Songhe, exercisable for shares of DYNAM Japanic Healthcare at a price equivalent to the loan in USD; and (3) After completing the overseas investment record for the subscription, Pengbo (Hainan) will repay the loan to Huada Songhe. Huada Songhe will then subscribe to shares of DYNAM Japanic Healthcare by exercising the warrants. In essence, the loan will be converted into shares of DYNAM Japanic Healthcare. Assuming that the Series A financing does not involve the subscription of additional shares of DYNAM Japanic Healthcare, Huada Songhe will hold up to 6.25% of the enlarged issued share capital of DYNAM Japanic Healthcare through the issuance of warrants and shares issued to the platform of Jabozhongzhi (Hainan) (Pengbo (Hainan) share incentive plan).